Johns Hopkins logo

Health Newsfeed

ADVANCED KIDNEY CANCER

A NEW MEDICATION APPEARS TO HELP IN ADVANCED KIDNEY CANCER, ELIZABETH TRACEY REPORTS

Everolimus is the name of a new medication given by mouth that’s shown a benefit in advanced kidney cancer, a study published in a recent issue of the journal Cancer showed.  Arthur Burnett, a urologist and surgeon at Johns Hopkins, describes the results.

BURNETT: What this oral therapy demonstrated with this study group that looked at this in a multi-institutional way in 416 patients it was demonstrated that there was a significant improvement in progression free survival .  The distinction was 4.9 months on the therapy versus 1.9 months on the placebo.  Now for this type of cancer once it gets to this progressed stage the concern is many patients do not fare well.  And so to even see a three month benefit here is fairly impressive.   :27

Burnett says the results should enable the drug to be approved by the FDA and may herald its use earlier in the course of kidney cancer.  At Johns Hopkins, I’m Elizabeth Tracey.


Search Health NewsFeed

-----------------------------------------
Health NewsFeed Home | Hopkins Medicine Home